Alkem Laboratories
India-based pharmaceutical company that operates globally.
Launch date
Employees
Market cap
£7.8b
Enterprise valuation
£7.5b (Public information from Sep 2024)
Share price
INR6127.3999 ALKEM.NS
Mumbai Maharashtra (HQ)
Financials
Estimates*
| INR | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenues | 81.9b | 87.3b | 105.1b | 116.0b | 124.4b | 10.5t |
| % growth | - | 7 % | 20 % | 10 % | 7 % | 8337 % |
| EBITDA | 15.9b | 20.8b | 21.9b | 18.3b | 25.3b | - |
| % EBITDA margin | 19 % | 24 % | 21 % | 16 % | 20 % | - |
| Profit | 11.3b | 15.9b | 16.5b | 9.8b | 18.0b | - |
| % profit margin | 14 % | 18 % | 16 % | 8 % | 14 % | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
$60.0m | - | ||
| Total Funding | £45.5m | ||
Related Content
Recent News about Alkem Laboratories
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
